Skip to main content
TipRanks
Go Ultimate75% OFF

Emergent Biosolutions (0IGA) Income Statement

4 Followers

Emergent Biosolutions Income Statement

Last quarter (Q3 2026), Emergent Biosolutions's total revenue was $110.00M, a decrease of 52.40% from the same quarter last year. In Q3, Emergent Biosolutions's net income was $-32.70M. See Emergent Biosolutions’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 742.90M$ 1.04B$ 1.05B$ 1.12B$ 1.77B
$ 350.60M$ 375.40M$ 360.00M$ 473.00M$ 793.20M
$ 240.40M$ 484.10M$ 1.09B$ 643.00M$ 451.80M
Depreciation and Amortization$ 95.80M$ 108.80M$ 125.10M$ 143.30M$ 123.80M
$ 237.90M$ 56.60M$ -43.00M$ 34.00M$ 509.80M
$ 110.20M$ -108.70M$ -726.40M$ -170.00M$ 341.40M
$ -27.40M$ -34.20M$ -4.80M$ -49.00M$ -38.20M
$ 82.80M$ -142.90M$ -731.20M$ -219.00M$ 303.20M
$ 52.60M$ -190.60M$ -760.50M$ -211.60M$ 219.50M
Per Share Metrics
Basic EPS$ 0.98$ -3.60$ -14.85$ -4.22$ 4.10
Diluted EPS$ 0.93$ -3.60$ -14.85$ -4.22$ 4.06
Weighted Average Shares Outstanding53.50M53.00M51.20M50.10M53.50M
Weighted Average Shares Outstanding (Diluted)56.70M53.00M51.20M50.10M54.10M

Currency in USD

Emergent Biosolutions Earnings and Revenue History

-1B01B2B-80 %-40 %0 %40 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin